
Opinion|Videos|October 24, 2024
Effective Balance of Approved Therapies and Patient Preferences
Author(s)Stuart H. Isaacson, MD, FAAN
Key Takeaways
- Patient-centered care involves understanding patient values and preferences alongside clinical efficacy and safety of therapies.
- Open communication and shared decision-making empower patients to actively participate in their treatment plans.
Dr. Isaacson discusses how health care providers can effectively balance the pharmacological properties of approved therapies for Parkinson's disease with patient preferences and comfort levels by fostering open communication and individualized care approaches.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How can healthcare providers effectively balance pharmacological properties of approved therapies with patient preferences and comfort levels?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
Building the Foundation for Earlier Alzheimer Disease Diagnosis
5













